Exploring heterogeneity using subgroup screeningClinical trials are often interested in how endpoints vary within racial or disease subgroups, which can lead to identifying patients who may benefit more from new treatments or who are at higher risk for safety issues.
This presentation introduces a new feature in JMP Clinical: subgroup screening. We discuss the limitations of the "By" role, the role of the new "Subgroup" in response screening, and the usefulness of UpSet plots for summarizing subgroups.
Data Exploration and Visualization
